|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Clinical and Experimental Therapeutics Program, University of Georgia College of Pharmacy, Augusta, GA, USA; Department of Vascular Biology Center, Medical College of Georgia, Augusta, GA, USA
2 Department of Clinical and Experimental Therapeutics Program, University of Georgia College of Pharmacy, Augusta, GA, USA
3 Department of Vascular Biology Center, Medical College of Georgia, Augusta, GA, USA
4 Department of Vascular Biology Center, Medical College of Georgia, Augusta, GA, USA; Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, GA, USA
* To whom correspondence should be addressed. E-mail: aergul{at}mail.mcg.edu.
Degradation of the extracellular matrix proteins by matrix metalloproteinases (MMP) is an important regulatory step in the vascular remodeling process. Recent studies demonstrated that ETA receptors regulate cardiac MMP activity and fibrosis in DOCA-salt hypertension. However, little is known about ET-1 regulation of vascular MMP activity in hypertension. Thus, early changes in ET-1-mediated regulation of MMP activity were measured in borderline hypertensive rats (BHR), which develop impaired vasorelaxation and hypertension with chronic exposure to stress. Experiments were performed after 10 days of exposure to the behavioral stressor, air-jet stress, but prior to the onset of stress-induced hypertension. Study groups were 1) control (n=8); 2) air jet stress for 10 days (n=8); 3) control plus ETA antagonist ABT627 (n=4), and 4) air jet stress plus ETA antagonist (n=4). MMP activity in the thoracic aorta was assessed by gelatin zymography. MMP protein and tissue ET-1 levels were evaluated by immunohistochemistry and ET receptor density was determined by immunoblotting. Exposure to stress caused a 2-fold increase in plasma ET-1 levels (p<0.05) and there was increased ET-1 staining at the tissue level . Total MMP activity and expression of MMP-2 and MMP-9 were increased in the stress group. ETA receptor antagonism prevented the increase in MMP expression and activation in the stress group. These results provide evidence that the MMP system is activated before the development of hypertension and ET-1 mediates these early events in vascular remodeling.
This article has been cited by other articles:
![]() |
B. Reel, G. Oktay, S. Ozkal, H. Islekel, E. Ozer, G. Ozsarlak-Sozer, Z. Cavdar, S. T. Akhisaroglu, and Z. Kerry MMP-2 and MMP-9 Alteration in Response to Collaring in Rabbits: The Effects of Endothelin Receptor Antagonism Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2009; 14(4): 292 - 301. [Abstract] [PDF] |
||||
![]() |
T. Matsumoto, K. Ishida, N. Nakayama, T. Kobayashi, and K. Kamata Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1388 - H1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Lund, J. Lucero, S. Lucas, M. C. Madden, J. D. McDonald, J.-C. Seagrave, T. L. Knuckles, and M. J. Campen Vehicular Emissions Induce Vascular MMP-9 Expression and Activity Associated With Endothelin-1-Mediated Pathways Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 511 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Watts, C. Rondelli, K. Thakali, X. Li, B. Uhal, M. H. Pervaiz, R. E. Watson, and G. D. Fink Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2438 - H2448. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Lund, T. L. Knuckles, C. Obot Akata, R. Shohet, J. D. McDonald, A. Gigliotti, J. C. Seagrave, and M. J. Campen Gasoline Exhaust Emissions Induce Vascular Remodeling Pathways Involved in Atherosclerosis Toxicol. Sci., February 1, 2007; 95(2): 485 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Wright, H. Tai, R. Wang, X. Wang, and A. Churg Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-{alpha} signaling Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L125 - L133. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Portik-Dobos, A. K. Harris, W. Song, J. Hutchinson, M. H. Johnson, J. D. Imig, D. M. Pollock, and A. Ergul Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R435 - R441. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Kadoglou, S. S. Daskalopoulou, D. Perrea, and C. D. Liapis Matrix Metalloproteinases and Diabetic Vascular Complications Angiology, March 1, 2005; 56(2): 173 - 189. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |